BlueWillow Biologics' Private Equity - II Round

BlueWillow Biologics raised a round of funding on February 24, 2009. Investors include Perseus.

BlueWillow Biologics is a privately-held biopharmaceutical company headquartered in Ann Arbor, Michigan, focused on developing and commercializing intranasal vaccines using its patented NanoVax┬« tech…

Articles about BlueWillow Biologics' Private Equity - II Round: